Moderna, a biotechnology company that is currently advancing a leading COVID-19 vaccine candidate, recently stated that it would not enforce its vaccine patents during the current health crisis. In light of this...more
10/27/2020
/ Biotechnology ,
Coronavirus/COVID-19 ,
Infectious Diseases ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
IP License ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Prosecution ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
USPTO ,
Vaccinations
For many charged with the development of intellectual property portfolios in the life sciences and software industries, navigating the stormy waters of patent eligibility has recently proven difficult. U.S. Supreme Court and...more
6/10/2016
/ Asset Seizure ,
Biotechnology ,
Defend Trade Secrets Act (DTSA) ,
Ex Parte ,
Intellectual Property Protection ,
Life Sciences ,
Misappropriation ,
New Legislation ,
Patent-Eligible Subject Matter ,
Private Right of Action ,
Software ,
Trade Secrets ,
Uniform Trade Secrets Acts ,
USPTO